NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1375632142|gb|AVW80988|]
View 

envelope glycoprotein I [Felid alphaherpesvirus 1]

Protein Classification

PHA03292 family protein( domain architecture ID 11476199)

PHA03292 family protein

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
PHA03292 PHA03292
envelope glycoprotein I; Provisional
1-384 0e+00

envelope glycoprotein I; Provisional


:

Pssm-ID: 177577  Cd Length: 413  Bit Score: 603.87  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142   1 MSSIAFIY---ILMAIG-TVYGIVYRGDHVSLHVDTSSGFVIYPTLENFTIYGHLIFLDDQPLPVNNYNGTLEIIHYNHH 76
Cdd:PHA03292    1 MAKCALLFwaaILLAIAaCATGIVYRGEHVSLYLDASSEFAVYPTDASLVLVGHLIFLDGQRLPTTNYNGTIELIHYNYS 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142  77 SSCYKIVQVIEYSSCPRVRNNAFRSCLHKTSMHQYDQLSINTSVETGMLLTITSPKMEDGGIYALRVRFNHNNKADVFGL 156
Cdd:PHA03292   81 SDCYVVIQTISYESCPRVANNAFRSCLHKTSRHNRDYFRVNASVETNVLLNITGPQPADSGAYILRVKLDHAPTADVFGL 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142 157 SVFVYSFDmrghrhhaDENLNGEILTT--PSPMETYVKVNTPIYDHMVTTqTTSNKSMESEPS----------------- 217
Cdd:PHA03292  161 SAFVYDFD--------SPTVPDPEPTTarPEPAAGYVATPTPRYLNAVTT-STYSRSMSSQPAgaatatptptldtgltt 231
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142 218 -----------NTSISCHTFQnDPNEGETLYTHLLNIAGNITYDDMVMDGTTL---KPRLIDMGLNLSVTSSFKNETTQK 283
Cdd:PHA03292  232 vappnetvvtgETALLCHWFQ-PSTRVPTLYLHLLGTTGNLTEDVLLTEDSEIlrtPPPDPSSSRSPGAGDDFKQTNSTS 310
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142 284 WTPDRKVGFVIVISIA--VLLLLAVIGSIINSAIRKHIMVCAGRRIYIPNNDGRPSTEMTRFTRQTKPSNSSSKSLLDVP 361
Cdd:PHA03292  311 PKRRNKIVAMIVIPTAcvVLLLLAVVGAIINGAVRKHLLSCASRRIYRPRQGGASSSERRRLTCGPTPAASSESLADDTT 390
                         410       420
                  ....*....|....*....|...
gi 1375632142 362 RSSNSTPTDGVSRSQLTVINEET 384
Cdd:PHA03292  391 VSPPSSKPKAKPKRKLEAIKEES 413
 
Name Accession Description Interval E-value
PHA03292 PHA03292
envelope glycoprotein I; Provisional
1-384 0e+00

envelope glycoprotein I; Provisional


Pssm-ID: 177577  Cd Length: 413  Bit Score: 603.87  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142   1 MSSIAFIY---ILMAIG-TVYGIVYRGDHVSLHVDTSSGFVIYPTLENFTIYGHLIFLDDQPLPVNNYNGTLEIIHYNHH 76
Cdd:PHA03292    1 MAKCALLFwaaILLAIAaCATGIVYRGEHVSLYLDASSEFAVYPTDASLVLVGHLIFLDGQRLPTTNYNGTIELIHYNYS 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142  77 SSCYKIVQVIEYSSCPRVRNNAFRSCLHKTSMHQYDQLSINTSVETGMLLTITSPKMEDGGIYALRVRFNHNNKADVFGL 156
Cdd:PHA03292   81 SDCYVVIQTISYESCPRVANNAFRSCLHKTSRHNRDYFRVNASVETNVLLNITGPQPADSGAYILRVKLDHAPTADVFGL 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142 157 SVFVYSFDmrghrhhaDENLNGEILTT--PSPMETYVKVNTPIYDHMVTTqTTSNKSMESEPS----------------- 217
Cdd:PHA03292  161 SAFVYDFD--------SPTVPDPEPTTarPEPAAGYVATPTPRYLNAVTT-STYSRSMSSQPAgaatatptptldtgltt 231
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142 218 -----------NTSISCHTFQnDPNEGETLYTHLLNIAGNITYDDMVMDGTTL---KPRLIDMGLNLSVTSSFKNETTQK 283
Cdd:PHA03292  232 vappnetvvtgETALLCHWFQ-PSTRVPTLYLHLLGTTGNLTEDVLLTEDSEIlrtPPPDPSSSRSPGAGDDFKQTNSTS 310
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142 284 WTPDRKVGFVIVISIA--VLLLLAVIGSIINSAIRKHIMVCAGRRIYIPNNDGRPSTEMTRFTRQTKPSNSSSKSLLDVP 361
Cdd:PHA03292  311 PKRRNKIVAMIVIPTAcvVLLLLAVVGAIINGAVRKHLLSCASRRIYRPRQGGASSSERRRLTCGPTPAASSESLADDTT 390
                         410       420
                  ....*....|....*....|...
gi 1375632142 362 RSSNSTPTDGVSRSQLTVINEET 384
Cdd:PHA03292  391 VSPPSSKPKAKPKRKLEAIKEES 413
Herpes_gI pfam01688
Alphaherpesvirus glycoprotein I; This family consists of glycoprotein I form various members ...
9-158 2.00e-31

Alphaherpesvirus glycoprotein I; This family consists of glycoprotein I form various members of the alphaherpesvirinae these include herpesvirus, varicella-zoster virus and pseudorabies virus. Glycoprotein I (gI) is important during natural infection, mutants lacking gI produce smaller lesions at the site of infection and show reduced neuronal spread. gI forms a heterodimeric complex with gE; this complex displays Fc receptor activity (binds to the Fc region of immunoglobulin). Glycoproteins are also important in the production of virus-neutralising antibodies and cell mediated immunity. The alphaherpesvirinae have a dsDNA gnome and have no RNA stage during viral replication.


Pssm-ID: 279953  Cd Length: 155  Bit Score: 116.84  E-value: 2.00e-31
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142   9 ILMAIGTVYGIVYRGDHVSLHVDTS--SGFVIYPTLENFTIYGHLIFLDDQPLPVNNYNGTLEIIHYNHHSSCYKIVQVI 86
Cdd:pfam01688   5 VGFWICLTTGLVVKGPTVSLVSDSSldVGACGPDKVVEEDVGGQLVFLGDQVPTTNYYDGTVELLHYPEGGKCPRVVHVV 84
                          90       100       110       120       130       140       150
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1375632142  87 EYSSCPRVRNNAFRSCLHKTSMHqYDQLSINTSVETGMlLTITSPKMEDGGIYALRVRFNHNNKADVFGLSV 158
Cdd:pfam01688  85 RYTACPRIPAVAFSGCRRTDSEH-YPTPEDRLATQPGL-LRIRTPTRDDAGVYVLRVWLDHAPNADAFRLGV 154
 
Name Accession Description Interval E-value
PHA03292 PHA03292
envelope glycoprotein I; Provisional
1-384 0e+00

envelope glycoprotein I; Provisional


Pssm-ID: 177577  Cd Length: 413  Bit Score: 603.87  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142   1 MSSIAFIY---ILMAIG-TVYGIVYRGDHVSLHVDTSSGFVIYPTLENFTIYGHLIFLDDQPLPVNNYNGTLEIIHYNHH 76
Cdd:PHA03292    1 MAKCALLFwaaILLAIAaCATGIVYRGEHVSLYLDASSEFAVYPTDASLVLVGHLIFLDGQRLPTTNYNGTIELIHYNYS 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142  77 SSCYKIVQVIEYSSCPRVRNNAFRSCLHKTSMHQYDQLSINTSVETGMLLTITSPKMEDGGIYALRVRFNHNNKADVFGL 156
Cdd:PHA03292   81 SDCYVVIQTISYESCPRVANNAFRSCLHKTSRHNRDYFRVNASVETNVLLNITGPQPADSGAYILRVKLDHAPTADVFGL 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142 157 SVFVYSFDmrghrhhaDENLNGEILTT--PSPMETYVKVNTPIYDHMVTTqTTSNKSMESEPS----------------- 217
Cdd:PHA03292  161 SAFVYDFD--------SPTVPDPEPTTarPEPAAGYVATPTPRYLNAVTT-STYSRSMSSQPAgaatatptptldtgltt 231
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142 218 -----------NTSISCHTFQnDPNEGETLYTHLLNIAGNITYDDMVMDGTTL---KPRLIDMGLNLSVTSSFKNETTQK 283
Cdd:PHA03292  232 vappnetvvtgETALLCHWFQ-PSTRVPTLYLHLLGTTGNLTEDVLLTEDSEIlrtPPPDPSSSRSPGAGDDFKQTNSTS 310
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142 284 WTPDRKVGFVIVISIA--VLLLLAVIGSIINSAIRKHIMVCAGRRIYIPNNDGRPSTEMTRFTRQTKPSNSSSKSLLDVP 361
Cdd:PHA03292  311 PKRRNKIVAMIVIPTAcvVLLLLAVVGAIINGAVRKHLLSCASRRIYRPRQGGASSSERRRLTCGPTPAASSESLADDTT 390
                         410       420
                  ....*....|....*....|...
gi 1375632142 362 RSSNSTPTDGVSRSQLTVINEET 384
Cdd:PHA03292  391 VSPPSSKPKAKPKRKLEAIKEES 413
PHA03290 PHA03290
envelope glycoprotein I; Provisional
7-347 6.12e-38

envelope glycoprotein I; Provisional


Pssm-ID: 165547  Cd Length: 357  Bit Score: 139.77  E-value: 6.12e-38
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142   7 IYILMAIGTVYGIVYRGDHVSLHVDTSSGFVIYPTLEN--FTIYGHLIFLDDQpLPV-NNYNGTLEIIHYNHHSSCYKIV 83
Cdd:PHA03290    9 SAMIFGIQCAAAIIFKGDHISLQVNSSATSIFIKMGNDndAEIKGQFLFIGDQ-FPTgNNYNGTLELLHADQTAFCFQPL 87
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142  84 QVIEYSSCPRVRNNAFRSCLHKTSMHQYDQL-SINTSVETGMLLTITSPKMEDGGIYALRVRFNHNNKADVFGLSVFVYS 162
Cdd:PHA03290   88 QRIMYDECPRIRTGAFIACRVKHSWHYENATdRILTDPDAEIIFKINKPGIEDAGIYLLLVQLDHSRLFDGFFLGLNVYP 167
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142 163 fdmrGHRHHadeNLNGEILTTPSPMETYvkvntpiydhmvttqttsnksMESEPSNTSISCHTFQNDPNEGETLYTHLLN 242
Cdd:PHA03290  168 ----AGDHH---NIEDVIYFPPSLQNGY---------------------SPRAIFNQAKICDKFATHKGMEQSIFQHILD 219
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142 243 IAGNITYDDMVMD----GTTLKPRLIDMGLNLSVTSSFKNETTQKWTPDRKVGFVIVISI--AVLLLLAVIGSIINSAIR 316
Cdd:PHA03290  220 LDADKELEDLPWLhddlGSTEKKSVVKEGFENDVKPNDMHELPEKLLEDPADNFLIAIPItaSLLIILAIIIVITIGIKR 299
                         330       340       350
                  ....*....|....*....|....*....|.
gi 1375632142 317 KHIMvcAGRRIYIPNNDGRPSTEMTRFTRQT 347
Cdd:PHA03290  300 RRSI--EKHKIYRPKRKKEQAITEKNARPES 328
Herpes_gI pfam01688
Alphaherpesvirus glycoprotein I; This family consists of glycoprotein I form various members ...
9-158 2.00e-31

Alphaherpesvirus glycoprotein I; This family consists of glycoprotein I form various members of the alphaherpesvirinae these include herpesvirus, varicella-zoster virus and pseudorabies virus. Glycoprotein I (gI) is important during natural infection, mutants lacking gI produce smaller lesions at the site of infection and show reduced neuronal spread. gI forms a heterodimeric complex with gE; this complex displays Fc receptor activity (binds to the Fc region of immunoglobulin). Glycoproteins are also important in the production of virus-neutralising antibodies and cell mediated immunity. The alphaherpesvirinae have a dsDNA gnome and have no RNA stage during viral replication.


Pssm-ID: 279953  Cd Length: 155  Bit Score: 116.84  E-value: 2.00e-31
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142   9 ILMAIGTVYGIVYRGDHVSLHVDTS--SGFVIYPTLENFTIYGHLIFLDDQPLPVNNYNGTLEIIHYNHHSSCYKIVQVI 86
Cdd:pfam01688   5 VGFWICLTTGLVVKGPTVSLVSDSSldVGACGPDKVVEEDVGGQLVFLGDQVPTTNYYDGTVELLHYPEGGKCPRVVHVV 84
                          90       100       110       120       130       140       150
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1375632142  87 EYSSCPRVRNNAFRSCLHKTSMHqYDQLSINTSVETGMlLTITSPKMEDGGIYALRVRFNHNNKADVFGLSV 158
Cdd:pfam01688  85 RYTACPRIPAVAFSGCRRTDSEH-YPTPEDRLATQPGL-LRIRTPTRDDAGVYVLRVWLDHAPNADAFRLGV 154
PHA03289 PHA03289
envelope glycoprotein I; Provisional
7-162 3.94e-21

envelope glycoprotein I; Provisional


Pssm-ID: 165546  Cd Length: 352  Bit Score: 93.45  E-value: 3.94e-21
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142   7 IYILMAIGTvYGIVYRGDHVSLHVDTSSGFVIYPTLENFTIYGHLIFLDDQPLpVNNYNGTLEIIHYNHHSSCYKIVQVI 86
Cdd:PHA03289    8 ILFCLIIGT-QSMVYTGTSVSTSTDQSAQVAFCGLDKVVNVYGKLLFLGDQYL-EESYSGTTEILKWNEANKCYSVAHAT 85
                          90       100       110       120       130       140       150
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1375632142  87 EYSSCPRVRNNAFRSClHKTSMHQYDQLSINTSVETGMLLTITSPKMEDGGIYALRVRFNHNNKADVFGLSVFVYS 162
Cdd:PHA03289   86 YYADCPIISSTVFRGC-RDAVVYARPHDRVHPQYEKGLLLTIIEPRMSDTGIYYIRVSLAGRNKSDIFRTSVFVCS 160
PHA03291 PHA03291
envelope glycoprotein I; Provisional
3-158 8.23e-12

envelope glycoprotein I; Provisional


Pssm-ID: 223033 [Multi-domain]  Cd Length: 401  Bit Score: 66.13  E-value: 8.23e-12
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142   3 SIAFIYILMAIGTVYGIVYRGDHVSLHVDT--------SSGFViyptLENFTIYGHLIFLDDQPLPVNNYNGTLEIIHYN 74
Cdd:PHA03291    4 PLGFLLALGLWACAAGVVVRGPTISLVSDSllaagavgADGSV----LEDLEVPGELHFLGPQVPHTTYYDGAVELFHYP 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1375632142  75 HHSSCYKIVQVIEYSSCPRVRNNAFRSC--LHKTSMHQYDQLSINTSVETgmLLTITSPKMEDGGIYALRVRFNHNNKAD 152
Cdd:PHA03291   80 PGDRCPRVVLVEELTACPRRPAVAFTLCrsTRRTQSPAYATLTLDLARQP--LLRARGAARAVVGLYVLRVWVEGATNAS 157

                  ....*.
gi 1375632142 153 VFGLSV 158
Cdd:PHA03291  158 LFPLGL 163
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH